Flagship launches startup to design and make lipid nanoparticles for genetic medicines

Ryan Cross

Senior Science Correspondent

Flagship Pioneering is betting $50 million that it can solve one of genetic medicine’s biggest problems — how to get the therapies to the right place …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Flagship launches startup to design and make lipid nanoparticles for genetic medicines

Ryan Cross

Senior Science Correspondent

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

Pfizer gets an FDA win in hemophilia after a rough week

VC firm targets $35M second fund to back startups led by scientists

Stealth BioTherapeutics CEO discusses surprise adcomm support for ultra-rare disease drug

Sanofi discontinues Denali-partnered MS trial after Phase 2 failure

Lilly follows the trend of new AI hires; Pfizer fills key UK position as activist hubbub swells

Exclusive: How an accidental email tipped Pfizer off to an activist investor’s plan

Flag­ship launch­es start­up to de­sign and make lipid nanopar­ti­cles for ge­net­ic med­i­cines

Senior Science Correspondent

Sign up to read this article for free.

more like this

Viridian Therapeutics

Waltham, MA, USA

Flagship launches startup to design and make lipid nanoparticles for genetic medicines